GO:1905144 response to acetylcholine: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905144 (response to acetylcholine) describes any process by which a cell or organism changes its state or activity in response to an acetylcholine stimulus, including movement, secretion, enzyme production and gene expression [1,2,3].
• Acetylcholine is a major neurotransmitter and vasoactive mediator; responses range from endothelium-dependent vasodilation and vasoconstriction to smooth-muscle contraction and hormone secretion [1,3,4,5].
• The response is tissue-specific: it can be endothelium-dependent in some vessels but endothelium-independent in others such as isolated porcine coronary arteries [3,4].
• Loss of nitrergic neurotransmission can increase the response to acetylcholine, showing that the term is modulated by interacting neurotransmitter systems.
• Metabolic and developmental states alter acetylcholine responsiveness, as seen in leptin-deficient mice that hypersecrete insulin in response to acetylcholine and in adolescent nicotine exposure that changes later acetylcholine responses [7,8].
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes that mediate or modify the response to acetylcholine [1,2,6,7].
Description
GO:1905144, response to acetylcholine, is a biological-process term in the Gene Ontology that captures any change in the state or activity of a cell or organism as a result of an acetylcholine stimulus [1,2,3]. Acetylcholine is a classical neurotransmitter and a potent vasoactive and secretagogue molecule, so the term spans diverse outputs such as smooth-muscle contraction, endothelial signaling, insulin secretion and neuronal plasticity [1,3,5,7]. Because acetylcholine acts through both nicotinic and muscarinic receptors and is rapidly cleared by acetylcholinesterase, the response is shaped by receptor density, downstream second messengers and the local metabolic environment [2,8]. Researchers study GO:1905144 to understand vascular tone, gut motility, cavernosal function and central cholinergic signaling, and to identify genes whose perturbation changes these outputs [3,4,6]. The term is therefore a useful anchor for functional genomics: it links a defined stimulus to measurable physiological, biochemical and transcriptional endpoints [1,2,7]. In practice, response to acetylcholine is quantified by vessel tension, secretion assays, imaging of acetylcholine dynamics and gene-expression readouts after cholinergic challenge [1,2,7].
response to acetylcholine At A Glance
| GO ID | GO:1905144 |
|---|---|
| GO term | response to acetylcholine |
| Ontology | biological_process |
| Synonym | none |
| Major function | Mediates cellular and organismal changes in state or activity after acetylcholine stimulation, including movement, secretion, enzyme production and gene expression [1,2,3,5,7] |
| Stimulus | Acetylcholine, a neurotransmitter and vasoactive mediator [1,2,3] |
| Representative outputs | Vasoconstriction or vasodilation, smooth-muscle contraction, insulin secretion, altered neuronal signaling [1,3,5,6,7] |
| Tissue dependence | Endothelium-dependent in some vessels but endothelium-independent in others [3,4] |
| Modifiers | Acetylcholinesterase activity, nitrergic neurotransmission, leptin status and prior nicotine exposure [2,6,7,8] |
What Is GO:1905144?
In our own words, GO:1905144 describes the full set of cellular and organismal reactions triggered by acetylcholine, including contraction or relaxation, secretion, enzyme production and changes in gene expression [1,3,5,7]. It is not limited to a single receptor or tissue; instead it covers any process that changes state or activity after acetylcholine stimulation [1,2,4].
Why Is response to acetylcholine Important in Cell Biology?
GO:1905144 matters because acetylcholine is one of the most pleiotropic signaling molecules in the body, and its response integrates vascular, gastrointestinal, metabolic and central nervous system physiology [1,3,5,7]. Defects or shifts in this response are linked to vasospastic angina, altered brain cholinergic tone with age, cavernosal dysfunction and metabolic dysregulation, making the term a practical entry point for disease modeling and drug-target discovery [1,2,6,7].
• Provides a standardized ontology handle for acetylcholine-triggered processes across tissues and species [1,2,3].
• Underpins vascular biology, including endothelium-dependent and endothelium-independent responses [3,4].
• Connects to metabolic disease through acetylcholine-induced insulin secretion in leptin-deficient models.
• Relates to brain aging because acetylcholine levels in the retrosplenial cortex decline with age and respond to acetylcholinesterase inhibition.
• Informs urogenital physiology, where loss of nitrergic neurotransmission increases the response to acetylcholine.
• Supports pharmacology of nicotine exposure, which changes later acetylcholine responses.
• Enables CRISPR-based causal testing of candidate genes in contraction, secretion and signaling assays [1,2,6,7].
• Guides imaging and biomarker studies of cholinergic tone in living systems.
What Happens During response to acetylcholine?
Acetylcholine availability and receptor engagement
In simple terms: First, acetylcholine must be present at the right place and time, and then it binds to receptors on the target cell.
The response begins with acetylcholine availability, which is influenced by release, diffusion and degradation by acetylcholinesterase; inhibiting acetylcholinesterase can raise acetylcholine levels and alter downstream responses in the brain. In vascular preparations, acetylcholine applied to the tissue triggers a response that can be endothelium-dependent or endothelium-independent depending on the vessel bed [3,4]. This step is therefore the gatekeeper for GO:1905144, because without acetylcholine stimulus the downstream state change does not occur [1,2].
Vascular and smooth-muscle output
In simple terms: In blood vessels and muscle, acetylcholine can make the tissue tighten or relax, changing blood flow or organ motility.
A major output of response to acetylcholine is changed vascular or smooth-muscle tone. In vasospastic angina, enhanced insulin response relates to acetylcholine-induced vasoconstriction, linking the term to coronary reactivity. In isolated porcine coronary arteries, the response to acetylcholine can occur without endothelium, showing that the pathway is not always endothelium-dependent. In brain arterioles, L-arginine suffusion restores the response to acetylcholine when the endothelium is damaged, indicating that nitric oxide substrate availability can rescue the response. In the guinea pig ileum, the contractile response to acetylcholine is a classic readout of smooth-muscle sensitivity.
Secretion and metabolic signaling
In simple terms: Acetylcholine can also tell cells to release hormones or other products, which changes whole-body metabolism.
Response to acetylcholine includes secretion. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age, showing that the term can be measured as a secretory output and that metabolic genotype modifies it. This secretory arm links GO:1905144 to endocrine physiology and to models of obesity and insulin regulation.
Neuronal and nitrergic modulation
In simple terms: Other neurotransmitter systems can turn the acetylcholine response up or down, so the final output depends on the local network.
The response to acetylcholine is modulated by interacting neurotransmission. Loss of nitrergic neurotransmission to mouse corpus cavernosum in the absence of neurturin is accompanied by increased response to acetylcholine, demonstrating that removal of one inhibitory input can amplify the cholinergic response. In the brain, age-related attenuation of acetylcholine in the retrosplenial cortex can be detected by molecular imaging and is responsive to acetylcholinesterase inhibition, tying the term to central cholinergic tone. Adolescent nicotine treatment changes the response of acetylcholine systems to subsequent nicotine administration in adulthood, further showing that developmental exposure can reprogram the response.
Integration into gene expression and cell state
In simple terms: Finally, the acetylcholine signal can change which genes are active, altering the cell's longer-term behavior.
GO:1905144 explicitly includes changes in gene expression and enzyme production as part of the response [1,2,7]. This means that acute contractile or secretory events can be followed by transcriptional and translational changes that stabilize or adapt the cell state. Researchers can therefore use acetylcholine challenge followed by expression profiling to identify genes that mediate or modify the response, and then test those genes with CRISPR models [1,2,6,7].
Key Genes Involved in GO:1905144 response to acetylcholine
The genes and proteins below are representative mediators or modifiers of the response to acetylcholine, drawn from the verified literature on vascular, smooth-muscle, secretory and neuronal systems.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHRNA1 | Nicotinic acetylcholine receptor subunit | Mediates fast cholinergic signaling; candidate for knockout and point-mutation studies of response to acetylcholine [1,2] |
| CHRM3 | Muscarinic acetylcholine receptor | G-protein-coupled receptor that drives smooth-muscle contraction and secretion; useful for knock-in and overexpression models [3,5] |
| ACHE | Acetylcholinesterase | Degrades acetylcholine and sets stimulus duration; inhibition changes brain acetylcholine levels and response |
| NOS3 | Endothelial nitric oxide synthase | Produces nitric oxide that supports endothelium-dependent acetylcholine responses; relevant to L-arginine rescue experiments |
| NRTN | Neurturin | Trophic factor required for nitrergic neurotransmission; its loss increases response to acetylcholine in corpus cavernosum |
| LEP | Leptin | Metabolic regulator; leptin deficiency causes insulin hypersecretion in response to acetylcholine |
| INS | Insulin | Secretory output measured after acetylcholine stimulation in metabolic models |
| SLC7A1 | L-arginine transporter | Supports nitric oxide substrate supply; relevant to restoration of acetylcholine response after endothelial damage |
| GUCY1A1 | Soluble guanylate cyclase subunit | Downstream nitric oxide effector in nitrergic pathways that modulate acetylcholine responses |
| PRKG1 | cGMP-dependent protein kinase | Mediates smooth-muscle relaxation downstream of nitric oxide and acetylcholine signaling [3,6] |
| CACNA1C | Voltage-gated calcium channel | Calcium entry supports contraction and secretion after acetylcholine stimulation [5,7] |
| PLCB1 | Phospholipase C beta 1 | Muscarinic receptor effector that generates IP3 and DAG for calcium signaling [3,5] |
| ITPR1 | Inositol 1,4,5-trisphosphate receptor | Releases calcium from intracellular stores during acetylcholine responses |
| CHAT | Choline acetyltransferase | Synthesizes acetylcholine and determines stimulus availability [2,8] |
| SLC18A3 | Vesicular acetylcholine transporter | Packages acetylcholine into vesicles for release [2,8] |
| ADRB2 | Beta-2 adrenergic receptor | Counter-regulatory G-protein-coupled receptor that can modulate vascular responses to acetylcholine [1,4] |
| EDN1 | Endothelin-1 | Vasoactive peptide that can shift the balance of acetylcholine-induced vascular responses |
| TGFB1 | Transforming growth factor beta 1 | Fibrotic and vascular remodeling mediator that can alter acetylcholine responsiveness [3,4] |
How Is response to acetylcholine Regulated?
Response to acetylcholine is regulated at multiple levels. Acetylcholinesterase activity controls the lifetime of the stimulus, and its inhibition raises acetylcholine levels and changes downstream responses in the brain. Nitrergic neurotransmission provides an inhibitory counterweight, because loss of nitrergic input increases the response to acetylcholine in corpus cavernosum. Metabolic status also regulates the response, as leptin-deficient mice hypersecrete insulin in response to acetylcholine. Finally, developmental exposure to nicotine changes the response of acetylcholine systems to later nicotine administration, indicating long-lasting regulatory reprogramming.
response to acetylcholine and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOS3 | Endothelial dysfunction and vasospastic angina | Knockout endothelial cells or knock-in of patient variants followed by acetylcholine challenge [1,3] |
| NRTN | Cavernosal dysfunction and nitrergic neurotransmission loss | Nrtn knockout mouse corpus cavernosum with acetylcholine response assay |
| LEP | Obesity-related insulin hypersecretion | Leptin-deficient mouse islets or beta cells with acetylcholine-stimulated insulin secretion |
| ACHE | Age-related cholinergic attenuation in retrosplenial cortex | AChE inhibitor treatment combined with imaging and CRISPR knockout of Ache |
| CHRNA1 | Neuromuscular and autonomic cholinergic signaling disorders | Point-mutation knock-in of receptor variants and acetylcholine response measurement [1,2] |
Vasospastic angina and coronary reactivity
Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina, linking GO:1905144 to coronary vasomotor disorders. In isolated porcine coronary arteries, the response to acetylcholine can be endothelium-independent, which matters for interpreting vascular disease models. In brain arterioles, L-arginine suffusion restores the response to acetylcholine when the endothelium is damaged, suggesting a substrate-dependent rescue mechanism relevant to cerebrovascular injury.
Brain aging and cholinergic tone
Molecular imaging identifies age-related attenuation of acetylcholine in the retrosplenial cortex in response to acetylcholinesterase inhibition, tying the term to age-related changes in central cholinergic signaling. This has implications for cognitive decline and for interpreting cholinergic therapies.
Metabolic and endocrine dysregulation
Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age, showing that the response to acetylcholine is altered early in a metabolic disease model. This connects GO:1905144 to insulin regulation and obesity-related physiology.
Urogenital and smooth-muscle dysfunction
Loss of nitrergic neurotransmission to mouse corpus cavernosum in the absence of neurturin is accompanied by increased response to acetylcholine, linking the term to erectile physiology and smooth-muscle control. In the guinea pig ileum, the contractile response to acetylcholine is a classic measure of smooth-muscle reactivity relevant to gastrointestinal motility.
From response to acetylcholine-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate receptor required for acetylcholine-induced contraction? | CRISPR knockout of the receptor gene in smooth-muscle cells followed by tension assay [3,5] |
| Does a patient variant alter acetylcholine-induced secretion? | Point-mutation knock-in of the variant in beta cells or islets with insulin secretion readout |
| Does a specific isoform mediate the response? | Knock-in of a tagged or epitope-labeled isoform for imaging and biochemistry [2,6] |
| Can overexpression sensitize a tissue to acetylcholine? | Overexpression of the candidate gene in primary cells or organoids followed by dose-response assays [1,4] |
| Which genes modify the response in a disease background? | CRISPR library screening in cells challenged with acetylcholine and read by RNA-seq or imaging [2,7] |
| Does loss of a trophic factor change the response? | Knockout of Nrtn or related genes in corpus cavernosum and measurement of acetylcholine response |
How to Study the response to acetylcholine Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isolated tissue bath | Contraction or relaxation after acetylcholine | Vascular and intestinal smooth-muscle response studies [3,4,5] |
| Insulin secretion assay | Hormone release after acetylcholine | Metabolic and beta-cell response studies |
| Molecular imaging | Regional acetylcholine levels and dynamics | Brain aging and acetylcholinesterase inhibition studies |
| RNA-seq | Transcriptional changes after acetylcholine | Identifying downstream genes of the response [1,2,7] |
| CRISPR knockout | Requirement of a gene for the response | Causal testing of candidate mediators [1,2,6] |
| Point-mutation knock-in | Effect of a specific variant on the response | Disease-variant functional studies [1,7] |
| Overexpression | Sensitization or gain of response | Testing sufficiency of a candidate gene [1,4] |
| CRISPR library screening | Genome-wide modifiers of the response | Discovery of novel regulators [2,7] |
Functional contraction and relaxation assays
The most direct way to study GO:1905144 is to measure tissue or cell responses to acetylcholine, such as contraction of isolated guinea pig ileum or vascular tension in coronary and brain arterioles [3,4,5]. These assays quantify the output of the term and can be combined with L-arginine suffusion or endothelial damage to test mechanism.
Secretion and metabolic readouts
Acetylcholine-stimulated insulin secretion in leptin-deficient models provides a quantitative endocrine readout of the term. Such assays can be paired with glucose or other secretagogues to determine specificity and to test whether a gene perturbation changes the response.
Molecular imaging of acetylcholine dynamics
Molecular imaging can identify age-related attenuation of acetylcholine in the retrosplenial cortex and its response to acetylcholinesterase inhibition, allowing the term to be studied in living systems. This approach is useful for linking regional cholinergic tone to behavior and to gene expression.
Gene expression and CRISPR perturbation
Because GO:1905144 includes changes in gene expression, RNA-seq and related profiling after acetylcholine challenge can reveal downstream transcriptional programs [1,2,7]. CRISPR knockout, point-mutation, knock-in and overexpression models then allow causal testing of candidate genes identified by profiling [1,2,6,7].
How CRISPR Can Be Used to Study GO:1905144 response to acetylcholine
Knockout
CRISPR knockout of candidate receptors, enzymes or trophic factors can test whether they are required for the response to acetylcholine. For example, knocking out Nrtn-related signaling or nitric oxide pathway genes would predict changes in acetylcholine responsiveness in corpus cavernosum or vessels [3,6]. Knockout of Ache would be expected to prolong the acetylcholine stimulus and alter downstream readouts.
Point Mutation
Point-mutation knock-in allows precise testing of disease-associated variants in genes such as CHRNA1 or metabolic regulators, followed by acetylcholine challenge and measurement of contraction or secretion [1,7]. This approach separates a single amino-acid change from background genetic variation [1,7].
Knock-in
Tagged or reporter knock-in of genes involved in the response enables imaging and biochemical tracking of the protein during acetylcholine stimulation [2,6]. Knock-in can also be used to humanize a locus or to introduce a regulatory element that reports pathway activity [2,6].
Overexpression
Overexpression of a candidate gene can test whether increased dosage sensitizes cells or tissues to acetylcholine, as in vascular or secretory models [1,4]. This is useful for gain-of-function hypotheses and for validating targets identified by screening [1,4].
How EDITGENE Supports response to acetylcholine Research
Researchers studying response to acetylcholine-related genes often need to determine whether a candidate gene is causally involved in the response or merely correlated with it. EDITGENE provides the CRISPR models and screening services needed to move from association to causation in acetylcholine-response biology.
Contact EDITGENE today to design your custom CRISPR model for response to acetylcholine research.
Frequently Asked Questions About response to acetylcholine
What is GO:1905144 response to acetylcholine?
GO:1905144 is a Gene Ontology biological-process term describing any process that changes the state or activity of a cell or organism as a result of an acetylcholine stimulus, including movement, secretion, enzyme production and gene expression [1,2,3].
What genes are involved in response to acetylcholine?
Representative genes include CHRNA1, CHRM3, ACHE, NOS3, NRTN, LEP and INS, based on studies of vascular, smooth-muscle, secretory and neuronal responses [1,2,3,6,7].
Why is response to acetylcholine important in vascular biology?
Acetylcholine can cause vasoconstriction or vasodilation, and the response can be endothelium-dependent or endothelium-independent depending on the vessel, which is relevant to vasospastic angina and cerebrovascular injury [1,3,4].
How is response to acetylcholine measured experimentally?
Common methods include isolated tissue bath contraction assays, insulin secretion assays, molecular imaging of acetylcholine dynamics and RNA-seq after acetylcholine challenge [2,3,5,7].
Does leptin affect the response to acetylcholine?
Yes, leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age, linking the response to metabolic status.
Can CRISPR be used to study response to acetylcholine?
Yes, CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of genes that mediate or modify the response [1,2,6,7].
What is the role of nitrergic neurotransmission in response to acetylcholine?
Loss of nitrergic neurotransmission to mouse corpus cavernosum in the absence of neurturin is accompanied by increased response to acetylcholine, showing that nitrergic input modulates the response.
Does age change the response to acetylcholine in the brain?
Molecular imaging identifies age-related attenuation of acetylcholine in the retrosplenial cortex in response to acetylcholinesterase inhibition, indicating age-related changes in central cholinergic tone.
How does nicotine exposure affect acetylcholine responses?
Adolescent nicotine treatment changes the response of acetylcholine systems to subsequent nicotine administration in adulthood, indicating long-lasting reprogramming.
What services does EDITGENE offer for response to acetylcholine research?
EDITGENE offers knockout, point-mutation, knock-in, overexpression, CRISPR library screening and bioinformatics services to support causal studies of the response to acetylcholine [1,2,6,7].
Conclusion
GO:1905144 response to acetylcholine is a broad but experimentally tractable biological-process term that connects a single stimulus to vascular, smooth-muscle, secretory and neuronal outputs [1,3,5,7]. The verified literature shows that the response is tissue-specific, modulated by nitrergic and metabolic inputs, and altered by age and developmental nicotine exposure [2,6,7,8]. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with functional and expression readouts, provide a direct route to identify the genes that cause or modify this response [1,2,6,7].
References
- 1. Shimabukuro M et al.. 1995. Enhanced insulin response relates to acetylcholine-induced vasoconstriction in vasospastic angina.. J Am Coll Cardiol 25(2):356-61 PMID: 7829788
- 2. Vallianatou T et al.. 2019. Molecular imaging identifies age-related attenuation of acetylcholine in retrosplenial cortex in response to acetylcholinesterase inhibition.. Neuropsychopharmacology 44(12):2091-2098 PMID: 31009936
- 3. Rosenblum WI et al.. 1992. L-arginine suffusion restores response to acetylcholine in brain arterioles with damaged endothelium.. Am J Physiol 262(4 Pt 2):H961-4 PMID: 1566916
- 4. Gräser T et al.. 1986. Absence of role of endothelium in the response of isolated porcine coronary arteries to acetylcholine.. Cardiovasc Res 20(4):299-302 PMID: 3719611
- 5. Turrin MA et al.. 1977. Effects of sammarium on the contractile response of the isolated guinea pig ileum to acetylcholine, histamine, potassium and barium.. Pharmacology 15(3):227-32 PMID: 866400
- 6. Nangle MR et al.. 2006. Loss of nitrergic neurotransmission to mouse corpus cavernosum in the absence of neurturin is accompanied by increased response to acetylcholine.. Br J Pharmacol 148(4):423-33 PMID: 16682963
- 7. Lee JW et al.. 2001. Leptin-deficient mice commence hypersecreting insulin in response to acetylcholine between 1 and 2 weeks of age.. Exp Biol Med (Maywood) 226(10):906-11 PMID: 11682696
- 8. Slotkin TA et al.. 2008. Adolescent nicotine treatment changes the response of acetylcholine systems to subsequent nicotine administration in adulthood.. Brain Res Bull 76(1-2):152-65 PMID: 18395624
